BILLERICA, Mass.--(BUSINESS WIRE)--
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader
insulin pump technology with its Omnipod® Insulin
Management System, today announced plans to release its financial
results for the third quarter of 2016 on November 3, 2016 after the
close of the financial markets. In connection with the release,
management will host a conference call that day at 4:30 p.m. (Eastern
The link to the live call will be available on the Investor Relations
section of the Company's website at http://investors.insulet.com,
"Events and Presentations," and will be archived for future reference.
You may also access the call by dialing (844) 831-3022 for domestic
callers or (315) 625-6887 for international callers, passcode is
84511802. A replay will be available two hours after the completion of
the call by dialing (855) 859-2056 (domestic) or (404) 537-3406
(international), passcode 84511802.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD) is an innovative medical device
company dedicated to making the lives of people with diabetes easier.
Through its Omnipod Insulin Management System, Insulet seeks to expand
the use of insulin pump therapy among people with insulin-dependent
diabetes. The Omnipod is a revolutionary and easy-to-use tubeless
insulin pump that features just two parts and a fully-automated cannula
insertion. Insulet's Delivery Systems business also partners with global
pharmaceutical and biotechnology companies to tailor the Omnipod
technology platform for the delivery of subcutaneous drugs across
multiple therapeutic areas. To read inspiring stories of people with
diabetes living their lives to the fullest with Omnipod, please visit
our customer blog, Suite D: http://suited.myomnipod.com.
Founded in 2000, Insulet Corporation is based in Billerica,
Massachusetts. For more information, please visit: http://www.myomnipod.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160927006577/en/
Investor Relations and Media Contact:
Deborah R. Gordon, 978-600-7717
Investor Relations and Corporate Communications
Source: Insulet Corporation
News Provided by Acquire Media